Try our beta test site
74 studies found for:    Open Studies | "Hypercholesterolemia"
Show Display Options
Rank Status Study
1 Recruiting French Observatory of Familial Hypercholesterolemia in Cardiology
Condition: Familial Hypercholesterolemia
Intervention:
2 Recruiting Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe
Condition: Hypercholesterolemia
Intervention: Drug: Rosuvastatin and Ezetimibe morning or evening administration
3 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
4 Recruiting The Spanish Familial Hypercholesterolaemia Cohort Study
Condition: Familial Hypercholesterolaemia
Intervention:
5 Recruiting EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA
Condition: HYPERCHOLESTEROLEMIA
Interventions: Dietary Supplement: CARDICHOL;   Dietary Supplement: PLACEBO
6 Recruiting Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: alirocumab SAR236553 (REGN727);   Drug: placebo for alirocumab;   Drug: ezetimibe;   Drug: placebo for ezetimibe;   Drug: atorvastatin;   Drug: rosuvastatin;   Drug: simvastatin
7 Recruiting Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Condition: Hypercholesterolemia
Interventions: Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo (for injection training only)
8 Recruiting MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)
Condition: Familial Hypercholesterolemia - Heterozygous
Intervention:
9 Recruiting Russian Familial Hypercholesterolemia Registry
Condition: Familial Hypercholesterolemia
Intervention:
10 Recruiting An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Condition: Hypercholesterolaemia
Interventions: Drug: alirocumab SAR236553 (REGN727);   Drug: statins;   Drug: ezetimibe;   Drug: cholestyramine;   Drug: fenofibrate;   Drug: omega-3 fatty acids;   Drug: nicotinic acid
11 Recruiting Open Label Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).
Condition: Familial Hypercholesterolemia
Intervention: Biological: evolocumab (AMG 145)
12 Recruiting Developing and Implementing Familial Hypercholesterolemia Registry
Condition: Familial Hypercholesterolemia
Intervention: Other: Cascade
13 Recruiting Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
Condition: Hypercholesterolemia, Familial
Intervention:
14 Recruiting A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Biological: AAV directed hLDLR gene therapy
15 Recruiting A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia
Condition: Homozygous Familial Hypercholesterolemia
Interventions: Drug: ALN-PCSSC;   Drug: Standard of Care
16 Recruiting Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Condition: Heterozygous Familial Hypercholesterolemia
Interventions: Drug: MGL-3196;   Drug: Placebo
17 Recruiting Atherosclerosis in Familial Hypercholesterolemia
Condition: Familial Hypercholesterolemia
Intervention: Other: CT coronary angiogram and carotid ultrasound
18 Recruiting A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
Condition: Hypercholesteremia
Interventions: Drug: Gemcabene 600 mg;   Drug: Placebo
19 Recruiting Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Conditions: Familial Hypercholesterolemia;   Lipid Disorder
Intervention:
20 Recruiting Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia
Conditions: Hypercholesterolemia;   Hypertriglyceridemia
Interventions: Dietary Supplement: VAL070-A;   Dietary Supplement: VAL070-B;   Dietary Supplement: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.